| Rethinking approaches of science, technology, and innovation in healthcare during the COVID-19 pandemic: the challenge of translating knowledge infrastructures to public needs RGL da Silva, R Chammas, HMD Novaes Health Research Policy and Systems 19, 1-9, 2021 | 35 | 2021 |
| Globalizing the scientific bandwagon: trajectories of precision medicine in China and Brazil L Au, RGL da Silva Science, Technology, & Human Values 46 (1), 192-225, 2021 | 26 | 2021 |
| A dinâmica do conhecimento biomédico e em saúde: uma interpretação sociológica MC da Costa, RGL da Silva Sociologias 21 (50), 18-47, 2019 | 14 | 2019 |
| University participation in the production of molecular diagnostic tests for the novel coronavirus in Brazil: the response to health challenges RGL Silva, R Chammas, GA Plonski, M Goldbaum, LCS Ferreira, ... Cadernos de Saúde Pública 36, e00115520, 2020 | 11 | 2020 |
| The institutional building of science and innovation diplomacy in Latin America: toward a comprehensive analytical typology RGL da Silva, GGC Ferreira, J Onuki, AJN Oliveira Frontiers in Research Metrics and Analytics 6, 654358, 2021 | 8 | 2021 |
| Interchangeability and substitution of biosimilars: is health technology assessment (HTA) a tool for decision-making? BO Ascef, RGL Silva, HA Oliveira Júnior, PCD Soárez Cadernos de Saúde Pública 35, e00087219, 2019 | 8 | 2019 |
| Long Covid requires a global response centred on equity and dialogue L Au, C Capotescu, A Curi, RGL da Silva, G Eyal Global Health Action 16 (1), 2023 | 7 | 2023 |
| A participação da universidade na produção de testes diagnósticos moleculares do novo coronavírus no Brasil: resposta aos desafios sanitários RGL SILVA, R Chammas, GA Plonski, M Goldbaum, LCS Ferreira, ... Cadernos de Saúde Pública 36 (6), e00115520, 2020 | 6 | 2020 |
| From lab to society: Fostering clinical translation of molecular systems engineering RGL da Silva, A Blasimme Bioengineering and Translational Medicine 9 (1), e10564, 2024 | 5 | 2024 |
| Organ chip research in Europe: players, initiatives, and policies RGL da Silva, A Blasimme Frontiers in Bioengineering and Biotechnology 11, 1237561, 2023 | 5 | 2023 |
| Instrumentos de Política de Ciência e Tecnologia em Genômica do Estado de São Paulo R Gonçalves Leonel da Silva, M Conceição da Costa Revista de Políticas Públicas 16 (2), 493-501, 2012 | 5* | 2012 |
| Tecnologia e política industrial na organização dos espaços de inovação RGL da Silva, MC da Costa Revista Economia & Tecnologia 8 (1), 2012 | 5 | 2012 |
| Como a comunidade internacional da medicina de precisão tem se posicionado diante dos desafios impostos pela pandemia da COVID-19? RGL Silva, JAB Iriart Cadernos de Saúde Pública 37, e00296920, 2021 | 4 | 2021 |
| Abordagens em ciência, tecnologia e sociedade M Marinho, SA da Silveira, M Monteiro, R de Brito Dias, C de Campos Santo André: Universidade Federal do ABC, 2014 | 4 | 2014 |
| The industry of therapeutic monoclonal antibodies in Brazil: Public policies as instruments of technology upgrading RGL da Silva, BB Fischer, PR Schaeffer, H Novaes Science and Public Policy 50 (1), 42–58, 2023 | 3 | 2023 |
| The Blind Spots of Sociotechnical Imaginaries: COVID-19 Scepticism in Brazil, the United Kingdom and the United States RG Leonel Da Silva, L Au Science, Technology and Society 27 (4), 611-629, 2022 | 3 | 2022 |
| Pathogenic imaginaries and Covid-19 denialism RGL da Silva European Association for the Study of Science and Technology 40 (1), 22-28, 2021 | 3* | 2021 |
| How Do Molecular Systems Engineering Scientists Frame the Ethics of Their Research? da Silva RGL, B A, V E, O K. AJOB Empirical Bioethics, 2024 | 2 | 2024 |
| Science, Technology and Innovation-oriented health centers, a COVID-19 legacy da Silva RGL, N HMD, C R. Annals of the Brazilian Academy of Sciences 93 (2), e20201469, 2021 | 2* | 2021 |
| Intercambialidade e substituição de biossimilares: seria a avaliação de tecnologias em saúde (ATS) um instrumento para tomada de decisão? BO Ascef, RGL Silva, HA Oliveira Júnior, PC Soárez Cadernos de Saúde Pública 35 (9), 1-6, 2019 | 2 | 2019 |
Hillegonda Maria Dutilh NovaesProfessora do Departamento de Medicina Preventiva, Faculdade de Medicina da Universidade de SãoVerified email at usp.br
